In vitro resistance of leukaemic blasts to prednisolone in bcr-abl positive childhood acute lymphoblastic leukaemia

Indian Journal of Medical Research

Volumn 116, Issue DEC., 2002, Pages 268-272

  Gupta, Mamta ^b   Kumar, Anil ^c   Dabadghao, Sunil ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c DEVI AHILYA UNIVERSITY   (India)

Author keywords

Acute lymphoblastic leukaemia; Glucocorticoid resistance; MTT assay; Philadelphia chromosome

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BCR ABL PROTEIN; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISOLONE; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASSAY; B LYMPHOCYTE; BLAST CELL; CELL LINEAGE; CHILD; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SENSITIVITY; FEMALE; FUSION GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFANT; LD 50; LEUKEMIA CELL LINE; MALE; PHILADELPHIA 1 CHROMOSOME; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ANTINEOPLASTIC AGENTS, HORMONAL; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY TESTS, IMMUNOLOGIC; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, ABL; HUMANS; INFANT; LEUKEMIA, B-CELL, ACUTE; LYMPHOCYTES; MALE; PHILADELPHIA CHROMOSOME; PREDNISOLONE; PROGNOSIS;

EID: 0038543344     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, et al. Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber ALL Consortium Protocol J Clin Oncol 2002; 20: 237-46.
2. Tosi P, Visani G, Ottaviani E, Manfroi S, Tura S. Biological and clinical significance of in vitro, prednisolone resistance in adult acute lymphoblastic leukaemia. Eur J Haematol 1996l; 57: 134-41.
3. Kaspers GJ, Pieters R, Klumper E, De Waal FC. Veerman AJ. Glucocorticoid resistance in childhood leukaemia. Leuk Lymphoma 1994; 13: 187-201.
4. Klumper E, Pieters R, Veerman AJP, Huismans DR, Loonen H, Hahlen K, et al. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukaemia. Blood 1995; 86: 3861-8.
5. Pieters R, Kaspers GJ, Van Wering ER, Huismans DR, Loonen AH, Hahlen K, et al. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukaemia. Leukemia 1993; 7: 392-7.
6. Eckun FM, Nachman JB, Sather HN, Sensel MG, Kraft P, Steinherz PG, et al. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: A report from the Children's Cancer Group. Cancer 1998; 83: 2030-9.
7. Yu Q, Brain J, Laneuville P, Osmond DG. Suppressed apoptosis of pre-B cells in bone marrow of pre-leukaemic p190 bcr/abl trangenic mice. Leukemia 2001; 15: 819-27.
8. Schuler D, Szende B, Borsi JD, Marton T, Bocsi J, Magyarossy E, et al. Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukaemia. Pediatr Hematol Oncol 1994; 11: 641-9.
9. Agarwal V, Dabadghao S, Misra MN, Nityand S. Immunophoneotypic subsets in acute lymphoblastic leukaemia from a single centre in north India: Correlation with outcome to induction chemotherapy. Indian J Cancer 2001; 38: 85-91.
10. Cross NC, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRANs in haematological disorders. Leukemia 1994; 8: 186-9.
11. Pieters R, Huismans DR, Leyva A, Veerman AJP. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukaemia. Cancer Lett 1988; 41: 323-32.
12. Young JC, Witte ON. Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures. Mol Cell Biol 1988; 8: 4079-87.
13. Csoka M, Bocsi J, Falus A, Szalai C, Klujber V, Szende B, et al. Glucocorticoid induced apoptosis and treatment sensitivity in acute lymphoblastic leukaemia of children. Pediatr Hematol Oncol 1997; 14: 433-42.
14. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002; 9: 6-19.
15. Cortez D, Stoica G, Pierce JH, Pendergast AM. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene 1996; 13: 2589-94.
16. Stiewe T, Parssanedjad K, Esche H, Opalka B, Putzer BM. EIA overcomes the apoptosis block in BCR-ABL + leukaemia cells and renders cell susceptible to induction of apoptosis by chemotherapeutic agents. Cancer Res 2000; 60: 3957-64.
17. Gupta M, Kumar A, Dabadghao S. Resistance of bcr-abl positive acute lymphoblastic leukaemia to daunorubicin is not mediated by mdr1 gene expression. Am J Hematol 2002; 71: 172-6.